Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (12116)	4/17/2019 1:32:57 PM
From: Another_Just_me	Read Replies (2) \| Respond to of 12871

With all the announced results of no adverse side effects, no toxicity, and great results from independent testing sources, IMHO a "fast track" designation is warranted. Especially with the unmet need for a treatment of shingles. AND then looking at the BIG picture of a family of cides the need for speed is even more compelling. Way too much suffering and deaths can be avoided when final approval is given. THE WORLD NEEDS A CURE FOR VIRUSES!